Although evidence about the effect of traditional DMARDs on psychological disorders is contradictory, some studies reported that new biologic DMARDs such as TNF-α antagonists could decrease depression symptoms in patients with RA (11). This evidence concerns the gene TNF and depressive symptom measurement.